Sep 21, 2026
What Makes a Liposomal NMN Powder Formulation Superior?
Liposomal NMN powder is usually described in marketing language, but the properties that decide how a grade behaves on a production line are measurable. Particle size distribution and polydispersity, encapsulation efficiency and the free fraction, moisture content and flowability, and lot-to-lot agreement with a published specification are the four attributes a technical buyer can verify against supply. The values referenced below come from the published grade specification for liposomal NMN powder, and each one can be held to in writing.
Why “Superior” Has to Be Expressed as a Specification
A formulation claim is only as strong as the attribute it points to. “Superior” becomes useful when it names the attribute, the method that produced the number, and an acceptance window a shipped lot can be judged against. If one of the three is missing, the claim cannot be checked on arrival. It begins with the manufacturing sequence that fixes these attributes.
The Four Quality Attributes That Decide How the Powder Behaves
For a spray-dried, phospholipid-encapsulated powder, four attributes account for most of the practical difference between grades.
- Particle size distribution and polydispersity — whether the vesicles are uniform enough to stay suspended, blend evenly and redisperse on demand.
- Encapsulation efficiency and the free fraction — how much of the active is associated with the bilayer and how much remains outside it.
- Moisture content and water activity — whether the powder stays free-flowing through storage, blending and filling.
- Flowability and redispersibility — how evenly the powder feeds into a blender or filler, and how it behaves when reconstituted.
Table 1 maps each attribute to what it governs, the routine method, and the detail worth requesting in writing. The same attribute logic carries across the wider nutraceutical ingredient range.
| Quality attribute | What it governs | Routine method | What to request |
|---|---|---|---|
| Particle size distribution | Suspendability, blending uniformity, filter behaviour | Dynamic light scattering (DLS) | Z-average, D10/D50/D90, dilution medium, temperature |
| Polydispersity index | Batch homogeneity, redispersion predictability | Derived from the DLS correlation function | A numeric PDI per lot, not a description |
| Encapsulation efficiency | How much active the phospholipid system carries | Separation-based assay; NMR for the encapsulated fraction | Definition, separation step, total assay of the same lot |
| Moisture and water activity | Caking, clumping and loss of flow | Karl Fischer titration; water activity meter | Release value and end-of-shelf-life value |
| Flowability | Feeding into blenders and filling lines | Angle of repose, Carr index, Hausner ratio | Test conditions as well as the result |
Particle Size Distribution and the Polydispersity Index
Dynamic light scattering is the standardized route to average hydrodynamic size and size distribution for submicrometre particles (ISO 22412:2025). A report gives a Z-average diameter, a distribution curve, and a polydispersity index (PDI) describing how broad that distribution is.
What a size report should contain
Ask for the Z-average, the D10, D50 and D90 percentiles, the PDI, the dilution medium, the equilibration temperature and the number of repeats. A single average hides the tail of the distribution, and the tail is what settles out, blocks a filter or redisperses unevenly.
Why PDI matters as much as average size
Two powders can share an average diameter and behave nothing alike. A narrow, monomodal distribution blends and redisperses predictably; a broad or bimodal one separates during blending, deposits sediment in a cold-water suspension, and looks different from one bag to the next. PDI is also the faster figure to compare lot to lot.
Sampling, not only measurement
Size measured on a diluted bench sample is not automatically the size distribution of the bagged powder. Request the sampling plan with the result, and check whether earlier lots used the same method. Where a grade is matched to a specific format, the practical checks are set out in matching a grade to your own formulation.
Encapsulation Efficiency and the Free-to-Encapsulated Ratio
Encapsulation efficiency (EE) is the share of total NMN associated with the phospholipid vesicles; the remainder is the free, unencapsulated fraction. Both figures belong in a specification, because a high EE quoted without the total assay says little about how much active the powder carries.
How the figure is produced
EE depends on how the free fraction is separated from the encapsulated one, so the method statement matters as much as the number. Separation-based assays quantify the free fraction and subtract it from the total; spectroscopic routes such as NMR characterize the encapsulated fraction. Ask which route produced the figure, whether the separation step was validated, and whether every lot is measured the same way.
Why one EE figure is not enough
Three details make an EE figure usable: the total NMN content of the same lot, the free fraction as a percentage of that total, and the trend across recent lots. A grade reporting 88% EE every time is easier to formulate around than one reporting 92% once and 81% the next time, because the second forces a compensating adjustment in your blend.
Composition and processing are the two levers. A 2025 review of liposomal encapsulation in food systems concludes that phospholipid type, sterol content and stabilizer choice determine encapsulation efficiency and mechanical stability, and that spray drying turns stable liposomes into powder form.
Moisture Content, Water Activity and Flowability
Moisture and water activity
Powders built on phospholipids around a hygroscopic active take up water from humid air. Residual moisture and water activity predict whether a bag stays free-flowing or cakes at the seam, and they are among the figures most often missing from a quotation. Ask for the release value, the method (Karl Fischer titration is routine) and the value at end of shelf life.
Flowability
Flowability governs how evenly the powder feeds into a blender, sachet filler or capsule filler. Angle of repose, Carr index and Hausner ratio are the usual descriptors, and each needs its test conditions stated to be comparable between suppliers. A powder that flows well in a dry laboratory can behave differently in a humid filling hall.
Redispersibility
Cold-water dispersibility is the attribute buyers most often test themselves, because it depends on the matrix they intend to use. Test the grade in your own liquid at your own solids loading, and record the time to dispersion and the appearance of the suspension. The published grade describes instant cold-water dispersibility with a stable nano-emulsion; the useful question is whether that holds in your system.
Published Specification Anchors for Liposomal NMN Powder
Table 2 collects the values published for EmerWell liposomal NMN powder. These are the figures a purchase specification can be built around; anything beyond them should be confirmed in writing for the specific lot.
| Parameter | Published specification |
|---|---|
| Appearance | White to off-white free-flowing fine powder |
| NMN content | 10% – 70% (customizable; 99% purity raw material) |
| Particle size (DLS) | Uniform particle size distribution |
| Encapsulation efficiency | 85% – 95% |
| Solubility | Instant cold-water dispersibility; forms a stable nano-emulsion |
| Stability | 24+ months (powder form, proper storage) |
| Testing methods | HPLC (purity), DLS (particle size), NMR (encapsulation) |
| Heavy metals (Pb) | < 0.1 ppm |
| Microbiology | Total plate count < 1,000 cfu/g |
| Certifications | cGMP, ISO 9001, ISO 22000, FSSC 22000, HACCP, HALAL, KOSHER, Non-GMO, Vegan |
| Packaging options | 1 kg (samples), 25 kg (standard), custom sizes available |
| Storage conditions | Cool, dry place; nitrogen-flushed multi-layer aluminum foil bags |
Batch Consistency: What to Compare Between Lots
Batch-to-batch consistency describes the relationship between lots, so it can only be judged across a series of certificates rather than from one. Table 3 is a reconciliation sheet: what to compare, how each figure is reported, and when a result deserves a written question.
| What to compare | How it is reported | How to compare across lots | When to ask |
|---|---|---|---|
| NMN assay | Percentage active by HPLC | Plot against the agreed tier, not the range limit | A value outside the tier, or a drift over three lots |
| Particle size and PDI | Z-average, percentiles and PDI by DLS | Same method, medium and temperature on every lot | A shift larger than the repeatability of the method |
| Encapsulation efficiency | Percentage of total active encapsulated | Compare only figures from the same separation route | A drop not matched by a change in total assay |
| Free fraction | Complement of EE, as a percentage | Read alongside the EE figure, not in isolation | An increase your blend cannot absorb |
| Moisture and water activity | Karl Fischer value; water activity | Compare release and end-of-shelf-life values separately | Any rise in water activity across stored lots |
Windows, not single points
An acceptance window should be wide enough to be producible and narrow enough to matter. Where a range is published, check whether it is the manufacturing window or the historical spread of results; the second is wider and will not flag a real process shift.
Trends before outliers
A single result outside a window is easy to spot; a slow drift across three consecutive lots is easier to miss and harder to correct, which is why the figures belong in a table rather than a filing cabinet. Repeat-order potency and purity is largely a records exercise. Two process variables explain most of the drift seen in practice: the grade of the phospholipid raw material and the drying step. Comparative work on freeze-dried and spray-dried encapsulated powders found that the drying route changes encapsulation efficiency, moisture content, particle size and oxidative stability, so one change to drying conditions can move several attributes at once.
Analytical Methods Behind the Numbers
Every figure should trace back to a named method. In this product family the published set is HPLC for purity, DLS for particle size and NMR for encapsulation, with microbiological counts and heavy metals tested separately. Two habits make that set more useful: ask for method references rather than method names, since “HPLC” describes an instrument family and not an assay; and ask whether each lot is tested in-house, by a third party, or both. Reading a liposomal NMN COA line by line covers the arithmetic that shows whether the figures on one certificate are internally consistent.
Weak Points to Look For in a Superiority Claim
- An attribute named without the method that produced it.
- An acceptance window wide enough to cover the whole plausible range.
- Particle size quoted as an average, with no distribution or PDI.
- Encapsulation efficiency quoted without the total assay for the same lot.
- Moisture reported at release only, with no end-of-shelf-life value.
How EmerWell Documents These Attributes
EmerWell supplies liposomal NMN powder with a batch Certificate of Analysis, particle size data from DLS, encapsulation data from NMR, stability information and a specification sheet, and can share method references and sampling plans for your vendor file. If you are comparing grades or drafting a specification, request the liposomal NMN powder specification sheet, a representative COA and a sample for bench trials, together with technical support on dispersibility, carrier compatibility and packaging. Send your requirements to info@emerwell-bio.com and the technical team will confirm which parameters are fixed, which remain customizable, and which documents accompany each lot.
References
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Liposome Drug Products: Chemistry, Manufacturing, and Controls — Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and
- International Organization for Standardization. ISO 22412:2025, Particle size analysis — Dynamic light scattering (DLS). https://www.iso.org/standard/85505.html
- Rahim, M. A., et al. (2025). Liposomal Encapsulation in Food Systems: A Review of Formulation, Processing, and Applications. Food Science & Nutrition. PMC12321603
- Koo, H., Kim, S., & Lee, J. (2023). Comparison of physicochemical properties and oxidative stability of microencapsulated perilla oil powder prepared by freeze-drying and spray-drying. Food Science and Biotechnology, 32(13), 1831–1839. PMC10541381
- Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 21 CFR Part 111. Electronic Code of Federal Regulations. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
This article is written for ingredient buyers, formulators and brand owners. It describes raw material properties, specification practice and documentation, and is not medical advice; nothing here should be read as a claim about the use or effect of any finished product.
Online Message